Drug Database
Back to search

Netherlands· NL-e101cdf8cbe9

Targretin 75 mg zachte capsules, capsules

A bexarotene product containing bexaroteen, registered in Netherlands by H.A.C. Pharma. The same ATC class is registered in 13 of our 19 countries.

ATC L01XF03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTargretin 75 mg zachte capsules, caps…ATCL01XF03REGISTER NO.NL-e101cdf8cbe9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bexaroteenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bexarotene is registered in 13 of 19 countries.

Countries holding a registration under ATC L01XF03 (bexarotene), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search bexarotene products by name

Bexarotene · ATC L01XF03

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BEXAROTEEN
Manufacturer
H.A.C. Pharma
Country
Netherlands (NL)
ATC code
L01XF03
ATC class
Bexarotene
Defined daily dose
0.54 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/01/178

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

573 interactions on record for bexarotene.

Graded by severity as the source publishes them — 127 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bexarotene against other medicinesHow interaction checks work

Bexarotene · interactions on record

573 records

  • 127 severe
  • 357 moderate
  • 80 minor
  • 9 info

Most severe, free to view

  • EluxadolineA07DA06severe
  • LiraglutidA08AX02severe
  • SemaglutidA08AX03severe
  • SitagliptinA10BH01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bexarotene in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bexarotene products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Bexagia
  • Germany · Bexaroten Cipla
  • Denmark · Bexarotene
  • Spain · Bexaroteno Cipla
  • Finland · Bexarotene Amdipharm
  • France · Bexarotene Cipla
  • United Kingdom (Northern Ireland) · Bexarotene Genus Pharmaceuticals Ltd.
  • Iceland · Targretin
  • Italy · Bexarotene Cipla
  • Liechtenstein · Targretin
  • Norway · Bexarotene Amdipharm, Targretin
  • Sweden · Bexarotene Amdipharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0ce1f2f1-4a36-4b92-ba3d-e42ca8f8e555
GET /v1/drugs/0ce1f2f1-4a36-4b92-ba3d-e42ca8f8e555?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/targretin-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Bexarotene",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70859",
  "excipients": [
    "1,4-SORBITAAN",
    "AMMONIA (E 527)",
    "BUTYLHYDROXYANISOL (E 320)",
    "GELATINE (E 441)",
    "GLYCEROL (E 422)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 400",
    "MACROGOL 400",
    "MANNITOL (D-) (E 421)",
    "POLYSORBAAT 20 (E 432)",
    "POLYVINYLACETAAFTALAAT",
    "POVIDON K 90 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)",
    "WATER, GEZUIVERD",
    "ZWARTE INKT"
  ],
  "substances": [
    "BEXAROTEEN"
  ],
  "leaflet_url": null,
  "authorised_at": "2001/03/29",
  "procedure_number": "EMEA/H/C/000326",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/01/178",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about bexarotene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console